GUIDELINE ON SAFETY AND EFFICACY FOLLOW-UP - RISK ...
Safety and efficacy follow-up systems form part of the Risk management system and should be planned in the EU-Risk management plan (EU-RMP). Both follow up systems are defined as any systematic collection and collation of data that is designed in a way that enables learning about safety and/or efficacy of an ATMP.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Related documents
Standard Operating Procedures - Occupational Safety and ...
www.osha.gov3.3 Safety and Health Management Plans 3.4 Work Control Plan Review Form 3.5 {Organization’s} Safety and Health Program Guideline (Date) 3.6 {Organization’s} Safety and Health Guideline for Job Hazards Analyses (Date) 3.7 Code of Federal Regulations, Title 29, Parts 1910, 1926, and 1960
Health, Guidelines, Safety, Health and safety, Health and safety guidelines
Job Safety Analysis (JSA) Guideline - .NET Framework
wslpwstoreprd.blob.core.windows.netJob Safety Analysis - Guideline Version 3.2 Example: Tip: Insert a new row for each hazard identified. How to Assess the Risk When we refer to risk in relation to occupational safety and health the most commonly used definition is 'risk is the likelihood that a person may be harmed or suffers adverse health effects if exposed to a hazard.'
Family Violence Assessment and Intervention Guideline
www.health.govt.nz1.4 Intervention/safety planning 45 1.5 Referral and follow-up 48 1.6 Documentation 49 Section 2: Intimate partner violence 52 2.1 Routine enquiry 52 2.2 Validation and support 55 2.3 Health and risk assessment 57 2.4 Safety planning 63 2.5 Referral and follow-up 68 2.6 Documentation 74
Health, Assessment, Guidelines, Family, Safety, Interventions, Violence, Family violence assessment and intervention guideline
Queensland Development Code Mandatory Part 6.1 ...
www.hpw.qld.gov.auSafety and Health Act 1999 or as part of a mine for the purposes of the Mining and Quarrying Safety and Health Act 1999; and for the commissioning of fire safety installations required for a building other than a class 1a building; or a class 10 building associated with a …
Guidance: Workplace Health and Safety
www.covid19.qld.gov.auHealth and Safety As at 17 December 2021 . More information For more information you can visit covid19.qld.gov.au. For general information about the Queensland Government’s response to COVID-19 you can call 134 COVID (13 42 68). The following provides guidance on …
Health and Safety Offences, Corporate Manslaughter and ...
www.sentencingcouncil.org.ukHealth and Safety at Work Act 1974 (section 33(1)(a) for breaches of sections 2, 3 and 7) Breach of Health and Safety regulations . Health and Safety at Work Act 1974 (section 33(1)(c)) Secondary Liability. Health and Safety at Work Act 1974 (sections 36 and 37(1) for breaches of sections 2 and 3 and section 33(1)(c)) Corporate manslaughter 21
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.eucommunication e.g. on the resolution of a safety concern or updated recommendations. • The effectiveness of safety communication should be evaluated where appropriate and possible (see XV.B.7.). • Safety communications should comply with relevant requirements relating to individual data protection and confidentiality.
Guidelines, Good, Practices, Safety, Guideline on good pharmacovigilance practices, Pharmacovigilance